SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Trickle Portfolio
An SI Board Since October 2000
Posts SubjectMarks Bans
1784 65 0
Emcee:  tuck Type:  Unmoderated
Introduction Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
1059I'll have to get back to you re AGNT (edit: old notes say consumables was 21tuck-2/12/2002
1058Well, according to them it will triple their chemistry consumables sales and EurJibacoa-2/11/2002
1057If I had any clue as to what Jones was worth, I could say whether or not I like tuck-2/11/2002
1056PKI's latest in liquid handling. PR only gives half the key numbers. For otuck-2/11/2002
1055Time for Caliper to start looking over their shoulder ? Fluidigm Announces Suppnigel bates-2/11/2002
1054Excellent quarter for BioRad. A split, even. They talked more about their Mad tuck-2/7/2002
1053Transgenomic Inc. and Max-Planck Institute for Molecular Genetics Collaborate Onnigel bates-2/7/2002
1052CRL met estimates and upped guidance. Trickle said it would buy CRL if it hit ttuck-2/6/2002
1051Caliper beats EPS estimates by a penny and revenue estimates by a million (abouttuck-2/6/2002
1050Nice Genomeweb article on low cost non-proprietory microarrays - genomeweb.comnigel bates-2/6/2002
1049It seems especially appropriate that Trickle should focus on liquid handling systuck-2/6/2002
1048>>BOTHELL, Wash., Feb. 6 /PRNewswire-FirstCall/ -- Epoch Biosciences, Inc.tuck-2/6/2002
1047LA JOLLA, Calif.--(BW HealthWire)--Feb. 6, 2002--The United States District Cournigel bates-2/6/2002
1046It is no accident ABI is languishing not far above multiyear lows following its tuck-2/4/2002
1045Trickle nibbles AFFX. 100 shares @ $27.75, the current ask. Cheers, Tucktuck-2/4/2002
1044HOUSTON--(BW HealthWire)--Feb. 4, 2002--Xeotron Corporation today announced thatnigel bates-2/4/2002
1043Here's the PR: >>BILLERICA, Mass., Feb 4, 2002 (BUSINESS WIRE) -- Brutuck-2/4/2002
1042From Genomeweb - <i>The company projects biodefense and chemical defense nigel bates-2/4/2002
1041joby, Fundamentally, I like CRS, mainly for the reasons you list. The sell wastuck-2/4/2002
1040Tuck, Care to elaborate on why rob.to was chosen to be dumped. I'm stilljsabelko-2/2/2002
1039OK, I'm gonna do QGENF, because it was an update, not an earnings call, thustuck-2/1/2002
1038>> before taking off for another cool weekend in Joshua Tree << Agascaram(o)uche-2/1/2002
1037Trickle just noticed that the January issue of Drug Discovery & Development tuck-2/1/2002
1036Trickle, sensing opportunities in the offing, raises some cash. Sells T.ROB at tuck-1/31/2002
1035Information that can be had elsewhere: genomeweb.com An overview of Andrew Shetuck-1/30/2002
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News